China Pharma Holdings, Inc. (CPHI) SEC Filings — 2025
8 SEC filings for China Pharma Holdings, Inc. (CPHI) in 2025.
Filings
- China Pharma Holdings Enters Material Agreement, Reports Equity Sales — 8-K · Dec 23, 2025
- China Pharma Holdings Files 8-K on Agreements and Equity Sales — 8-K · Dec 10, 2025
- CPHI Proposes 1:20 Reverse Stock Split, Boosts CEO Pay to $241,600 — DEF 14A · Nov 14, 2025
- China Pharma Holdings Grapples with Mounting Losses, Liquidity Concerns — 10-Q · Nov 12, 2025
- China Pharma Narrows Loss Amidst Revenue Dip, Going Concern Doubts Linger — 10-Q · Aug 14, 2025
- China Pharma Holdings Files 10-Q for Q1 2025 — 10-Q · May 14, 2025
- China Pharma Holdings Files 8-K — 8-K · Apr 4, 2025
- China Pharma Holdings Files 2024 Annual Report — 10-K · Mar 31, 2025